Meeting
2021 Genitourinary Cancers Symposium
Evaluation of germline genetic testing criteria in early-onset kidney cancer.
Authors
Hong Truong
Memorial Sloan Kettering Cancer Center, New York, NY
Hong Truong , Rania Sheikh , Ritesh Kotecha , Yelena Kemel , Aliya Khurram , Peter Reisz , Andrew Thomas Lenis , Vijai Joseph , Diana Mandelker , Chung-Han Lee , Darren R. Feldman , Martin H Voss , Jonathan Coleman , Paul Russo , Zsofia Kinga Stadler , A. Ari Hakimi , Robert J. Motzer , Kenneth Offit , Sujata Patil , Maria Isabel Carlo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 296)
DOI
10.1200/JCO.2021.39.6_suppl.296
Abstract #
296
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility.
First Author: Scott T. Michalski
Poster
2021 ASCO Annual Meeting
Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types.
First Author: Kristen Hanson
Poster
2022 ASCO Annual Meeting
Impact of cancer susceptibility gene (CSG) mutations in advanced NSCLC (aNSCLC).
First Author: Danielle Klingberg
Poster
2022 ASCO Genitourinary Cancers Symposium
Putative germline findings in tumor-only and liquid biopsy sequencing in veterans with aggressive prostate cancer.
First Author: Kara Noelle Maxwell